5 AI-Powered Companies Transforming the Future of Fertility Care

by Dana Sokolova    Contributor        Biopharma insight

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

  
Topics: Biotech Companies   
Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email

The field of fertility treatments is experiencing a surge in demand, fueled by several significant factors. A shift towards starting families at a later age, the increasing number of same-sex couples seeking assistance, and concerning studies revealing a decline in male fertility are all contributing to this trend. According to the Pew Research Center, the use of fertility treatments to assist with the birth process in the US has more than tripled from 1996 to 2015.

Presently, one in every eight couples encounters challenges with infertility, and the available treatment options often come with a hefty price tag. In the United States, a single cycle of in vitro fertilization (IVF) costs approximately $12,000, with medication expenses driving the total up to $25,000. It's important to note that many patients typically require three to five cycles on average in order to achieve a successful pregnancy.

Developing countries also face significant infertility issues, affecting one in four couples worldwide. Overall, around 48.5 million couples globally struggle with infertility, and this condition is rapidly emerging as an epidemic.

Although IVF has been a widely used technique for over four decades, its outcomes remain unpredictable. Furthermore, access to fertility care remains dishearteningly low. In developed markets such as the United States, only 2% of individuals grappling with infertility have used IVF as a solution.

In his comment to Forbes Eran Eshed, the CEO of Fairtility, highlights the stagnation of data and artificial intelligence (AI) usage in influencing IVF outcomes, despite numerous advancements in biotechnology. Eshed emphasizes that while data science cannot resolve biological challenges, AI has the potential to revolutionize the IVF process by enhancing decision-making at every critical juncture. These advancements hold the promise of boosting embryologists' efficiency by up to 50% and increasing the chances of achieving a live birth by 4%.

Now, let's delve into the realm of fertility technology and explore five companies that are advancing the integration of AI to revolutionize the field.

 

ImVitro

Continue reading

This content available exclusively for BPT Mebmers

Topics: Biotech Companies   

Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email

Comments